Related references
Note: Only part of the references are listed.Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
Tissue Factor and PAR2 Signaling in the Tumor Microenvironment
Florence Schaffner et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
rNAPc2 Inhibits Colorectal Cancer in Mice through Tissue Factor
Jingsong Zhao et al.
CLINICAL CANCER RESEARCH (2009)
Phosphorylation of Protease-activated Receptor-2 Differentially Regulates Desensitization and Internalization
Tiffany K. Ricks et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Embryonic stem cell tumor model reveals role of vascular endothelial receptor tyrosine phosphatase in regulating Tie2 pathway in tumor angiogenesis
Zhe Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Contribution of Host-Derived Tissue Factor to Tumor Neovascularization
Joanne Yu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice
Henri H. Versteeg et al.
CANCER RESEARCH (2008)
Tumor endothelial cell tube formation model for determining anti-angiogenic activity of a tRNA synthetase cytokine
Quansheng Zhou et al.
METHODS (2008)
Inhibition of tissue factor signaling suppresses tumor growth
Henri H. Versteeg et al.
BLOOD (2008)
Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells
T. Albrektsen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
β-arrestin-dependent regulation of the cofilin pathway downstream of protease-activated receptor-2
Maria Zoudilova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and -independent mechanisms
Joseph S. Palumbo et al.
BLOOD (2007)
Differential effects of β-arrestins on the internalization, desensitization and ERK1/2 activation downstream of protease activated receptor-2
P. Kumar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Regulation of macrophage procoagulant responses by the tissue factor cytoplasmic domain in endotoxemia
Jasimuddin Ahamed et al.
BLOOD (2007)
Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis
Hannele Uusitalo-Jarvinen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Overview of the Postulated Mechanisms Linking Cancer and Thrombosis
Hugo ten Cate et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2007)
Oncogenes, Trousseau syndrome, and cancer-related changes in the coagulome of mice and humans
Janusz Rak et al.
CANCER RESEARCH (2006)
Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype
Mary Lynn Nierodzik et al.
CANCER CELL (2006)
Protease-activated receptor-2 simultaneously directs β-arrestin-1-dependent inhibition and Gαq-dependent activation of phosphatidylinositol 3-kinase
Ping Wang et al.
BIOCHEMISTRY (2006)
Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways
Yingmei Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Proangiogenic effects of protease-activated receptor 2 are tumor necrosis factor-α and consecutively tie2 dependent
T Zhu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Thrombin generation and the pathogenesis of cancer
Wolfram Ruf et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2006)
Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis
F Noorbakhsh et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells
DR Morris et al.
CANCER RESEARCH (2006)
Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling
M Riewald et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study
LC Petersen et al.
THROMBOSIS RESEARCH (2005)
Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration
GM Hjortoe et al.
BLOOD (2004)
Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion
MA Booden et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Cross-talk of integrin α3β1 and tissue factor in cell migration
A Dorfleutner et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both β-arrestin-1 and -2
L Ge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Reduction in arthritis severity and modulation of immune function in tissue factor cytoplasmic domain mutant mice
YH Yang et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain
J Ahamed et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Regulation of angiogenesis by tissue factor cytoplasmic domain signaling
M Belting et al.
NATURE MEDICINE (2004)
Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases
EY Lin et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor
JC Rodríguez-Manzaneque et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor
M Riewald et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
β-Arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2
KA DeFea et al.
JOURNAL OF CELL BIOLOGY (2000)
Share Paper
